{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,11]],"date-time":"2026-07-11T00:15:59Z","timestamp":1783728959781,"version":"3.55.0"},"reference-count":56,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"29","license":[{"start":{"date-parts":[[2023,7,21]],"date-time":"2023-07-21T00:00:00Z","timestamp":1689897600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2023,7,21]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>\n                      Hepatic fibrosis is a great concern in public health. While effective drugs for its treatment are lacking,\n                      <jats:italic toggle=\"yes\">Curcuma longa L.<\/jats:italic>\n                      (CL) has been reported as a promising therapeutic. We aimed to uncover the core components and mechanisms of CL against hepatic fibrosis via a network pharmacology approach.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>The main components of CL were obtained and screened. While targets of components and disease were respectively collected using SwissTargetPrediction and online databases, common targets were assessed. A protein\u2013protein interaction (PPI) network was constructed, and core targets were identified. GO and KEGG pathway enrichment analyses were performed, and molecular docking was conducted to validate the binding of core components in CL on predicted core targets.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>Nine main components from CL based on high-performance liquid chromatography (HPLC) and 63 anti-fibrosis targets were identified, and a PPI network and a component target-disease target network were constructed. Apigenin, quercetin, demethoxycurcumin, and curcumin are likely to become key phenolic-based components and curcuminoids for the treatment of hepatic fibrosis, respectively. KEGG pathway enrichment analysis revealed that the HIF-1 signaling pathway (hsa04066) was most significantly enriched. Considering core targets of the PPI network and a network of the common targets and pathways enriched, AKT1, MAPK1, EGFR, MTOR, and SRC may be the core potential targets of CL against hepatic fibrosis. Molecular docking was carried out to verify the binding of above core components to core targets.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions:<\/jats:title>\n                    <jats:p>The therapeutic effect of CL on hepatic fibrosis may be attributed to multi-components, multi-targets, and multi-pathways.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/md.0000000000034353","type":"journal-article","created":{"date-parts":[[2023,7,21]],"date-time":"2023-07-21T14:47:45Z","timestamp":1689950865000},"page":"e34353","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":10,"title":["Mechanisms of main components in Curcuma longa L. on hepatic fibrosis based on network pharmacology and molecular docking: A review"],"prefix":"10.1097","volume":"102","author":[{"given":"Qiang","family":"Han","sequence":"first","affiliation":[{"name":"Department of Traditional Chinese Medicine, Health Service Center of Beiyuan Community, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiahui","family":"Zhu","sequence":"additional","affiliation":[{"name":"Faculty of Rehabilitation Medicine, Binzhou Medical University, Yantai, Shandong Province, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0215-3572","authenticated-orcid":false,"given":"Peng","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Hepatology, Beijing University of Chinese Medicine Affiliated Dongfang Hospital, Beijing, China."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20260710","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1016\/S0140-6736(20)30925-9","article-title":"Global burden of 369 diseases and injuries in 204 countries and territories, 1990-2019: a systematic analysis for the global burden of disease study 2019.","volume":"396","year":"2020","journal-title":"Lancet"},{"key":"R2-20260710","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1038\/s41575-020-00372-7","article-title":"Molecular and cellular mechanisms of liver fibrosis and its regression.","volume":"18","author":"Kisseleva","year":"2021","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"R3-20260710","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.addr.2017.05.007","article-title":"Hepatic stellate cells as key target in liver fibrosis.","volume":"121","author":"Higashi","year":"2017","journal-title":"Adv Drug Deliv Rev"},{"key":"R4-20260710","doi-asserted-by":"crossref","first-page":"112442","DOI":"10.1016\/j.jep.2019.112442","article-title":"Advances in anti hepatic fibrotic therapy with Traditional Chinese Medicine herbal formula.","volume":"251","author":"Li","year":"2020","journal-title":"J Ethnopharmacol"},{"key":"R5-20260710","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.jhep.2014.03.009","article-title":"Traditional Chinese Medicine (TCM) for fibrotic liver disease: hope and hype.","volume":"61","author":"Zhang","year":"2014","journal-title":"J Hepatol"},{"key":"R6-20260710","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/S2221-1691(11)60026-9","article-title":"Hepatoprotective and immunomodulatory properties of aqueous extract of Curcuma longa in carbon tetra chloride intoxicated Swiss albino mice.","volume":"1","author":"Sengupta","year":"2011","journal-title":"Asian Pac J Trop Biomed"},{"key":"R7-20260710","doi-asserted-by":"crossref","first-page":"e13085","DOI":"10.1111\/jfbc.13085","article-title":"Nutrient mixture from germinated legumes: enhanced medicinal value with herbs-attenuated liver cirrhosis.","volume":"44","author":"Nithyananthan","year":"2020","journal-title":"J Food Biochem"},{"key":"R8-20260710","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.jtcme.2016.05.005","article-title":"Biological activities of curcuminoids, other biomolecules from turmeric and their derivatives\u2014a review.","volume":"7","author":"Amalraj","year":"2017","journal-title":"J Tradit Complement Med"},{"key":"R9-20260710","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1002\/mnfr.201200838","article-title":"Curcumin-free turmeric exhibits anti-inflammatory and anticancer activities: identification of novel components of turmeric.","volume":"57","author":"Aggarwal","year":"2013","journal-title":"Mol Nutr Food Res"},{"key":"R10-20260710","doi-asserted-by":"crossref","first-page":"3785","DOI":"10.1007\/s11010-021-04201-6","article-title":"Turmeric and its bioactive constituents trigger cell signaling mechanisms that protect against diabetes and cardiovascular diseases.","volume":"476","author":"Zhang","year":"2021","journal-title":"Mol Cell Biochem"},{"key":"R11-20260710","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1186\/1472-6882-13-56","article-title":"Hepatoprotective effect of ethanolic extract of Curcuma longa on thioacetamide induced liver cirrhosis in rats.","volume":"13","author":"Salama","year":"2013","journal-title":"BMC Complement Altern Med"},{"key":"R12-20260710","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1002\/ptr.2764","article-title":"Study on antifibrotic effects of curcumin in rat hepatic stellate cells.","volume":"23","author":"Lin","year":"2009","journal-title":"Phytother Res"},{"key":"R13-20260710","doi-asserted-by":"crossref","first-page":"7440","DOI":"10.1038\/s41598-020-64293-w","article-title":"Novel combinatorial regimen of garcinol and curcuminoids for Non-alcoholic Steatohepatitis (NASH) in Mice.","volume":"10","author":"Majeed","year":"2020","journal-title":"Sci Rep"},{"key":"R14-20260710","doi-asserted-by":"crossref","first-page":"8761435","DOI":"10.1155\/2020\/8761435","article-title":"Preclinical evidence of Curcuma longa and its noncurcuminoid constituents against hepatobiliary diseases: a review.","volume":"2020","author":"An","year":"2020","journal-title":"Evid Based Complement Alternat Med"},{"key":"R15-20260710","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1007\/s11130-019-00733-x","article-title":"Turmeric extract: potential use as a prebiotic and anti-inflammatory compound?","volume":"74","author":"Ghiamati Yazdi","year":"2019","journal-title":"Plant Foods Hum Nutr"},{"key":"R16-20260710","doi-asserted-by":"crossref","first-page":"42717","DOI":"10.1038\/srep42717","article-title":"SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules.","volume":"7","author":"Daina","year":"2017","journal-title":"Sci Rep"},{"key":"R17-20260710","doi-asserted-by":"crossref","first-page":"W357","DOI":"10.1093\/nar\/gkz382","article-title":"SwissTargetPrediction: updated data and new features for efficient prediction of protein targets of small molecules.","volume":"47","author":"Daina","year":"2019","journal-title":"Nucleic Acids Res"},{"key":"R18-20260710","doi-asserted-by":"crossref","first-page":"D901","DOI":"10.1093\/nar\/gkm958","article-title":"DrugBank: a knowledgebase for drugs, drug actions and drug targets.","volume":"36","author":"Wishart","year":"2008","journal-title":"Nucleic Acids Res"},{"key":"R19-20260710","first-page":"D1031","article-title":"Therapeutic target database 2020: Enriched resource for facilitating research and early development of targeted therapeutics.","volume":"48","author":"Wang","year":"2020","journal-title":"Nucleic Acids Res"},{"key":"R20-20260710","doi-asserted-by":"crossref","first-page":"D605","DOI":"10.1093\/nar\/gkaa1074","article-title":"The STRING database in 2021: customizable protein\u2013protein networks, and functional characterization of user-uploaded gene\/measurement sets.","volume":"49","author":"Szklarczyk","year":"2021","journal-title":"Nucleic Acids Res"},{"key":"R21-20260710","doi-asserted-by":"crossref","first-page":"2498","DOI":"10.1101\/gr.1239303","article-title":"Cytoscape: a software environment for integrated models of biomolecular interaction networks.","volume":"13","author":"Shannon","year":"2003","journal-title":"Genome Res"},{"key":"R22-20260710","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/1471-2105-4-2","article-title":"An automated method for finding molecular complexes in large protein interaction networks.","volume":"4","author":"Bader","year":"2003","journal-title":"BMC Bioinform"},{"key":"R23-20260710","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1038\/s41467-019-09234-6","article-title":"Metascape provides a biologist-oriented resource for the analysis of systems-level datasets.","volume":"10","author":"Zhou","year":"2019","journal-title":"Nat Commun"},{"key":"R24-20260710","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1093\/nar\/30.1.245","article-title":"The protein data bank: unifying the archive.","volume":"30","author":"Westbrook","year":"2002","journal-title":"Nucleic Acids Res"},{"key":"R25-20260710","doi-asserted-by":"crossref","first-page":"W270","DOI":"10.1093\/nar\/gkr366","article-title":"SwissDock, a protein-small molecule docking web service based on EADock DSS.","volume":"39","author":"Grosdidier","year":"2011","journal-title":"Nucleic Acids Res"},{"key":"R26-20260710","first-page":"1","article-title":"Curcumin and Curcuma longa L. extract ameliorate lipid accumulation through the regulation of the endoplasmic reticulum redox and ER stress.","volume":"7","author":"Lee","year":"2017","journal-title":"Sci Rep"},{"key":"R27-20260710","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1186\/s12906-015-0773-6","article-title":"Pre-administration of turmeric prevents methotrexate-induced liver toxicity and oxidative stress.","volume":"15","author":"Moghadam","year":"2015","journal-title":"BMC Complement Altern Med"},{"key":"R28-20260710","doi-asserted-by":"crossref","first-page":"2323","DOI":"10.1039\/D0FO02910F","article-title":"Apigenin protects mice against 3,5-diethoxycarbonyl-1,4-dihydrocollidine-induced cholestasis.","volume":"12","author":"Zheng","year":"2021","journal-title":"Food Funct"},{"key":"R29-20260710","doi-asserted-by":"crossref","first-page":"117475","DOI":"10.1016\/j.lfs.2020.117475","article-title":"Transcriptomics and proteomics analysis of system-level mechanisms in the liver of apigenin-treated fibrotic rats.","volume":"248","author":"Qiao","year":"2020","journal-title":"Life Sci"},{"key":"R30-20260710","first-page":"6651839","article-title":"Apigenin alleviates liver fibrosis by inhibiting hepatic stellate cell activation and autophagy via TGF-\u03b21\/Smad3 and p38\/PPAR\u03b1 pathways.","author":"Ji","year":"2021","journal-title":"PPAR Res"},{"key":"R31-20260710","doi-asserted-by":"crossref","first-page":"1865","DOI":"10.1111\/j.1440-1746.2012.07262.x","article-title":"Quercetin improves hepatic fibrosis reducing hepatic stellate cells and regulating pro-fibrogenic\/anti-fibrogenic molecules balance.","volume":"27","author":"Hern\u00e1ndez-Ortega","year":"2012","journal-title":"J Gastroenterol Hepatol"},{"key":"R32-20260710","doi-asserted-by":"crossref","first-page":"72","DOI":"10.3389\/fphar.2018.00072","article-title":"The flavonoid quercetin ameliorates liver inflammation and fibrosis by regulating hepatic macrophages activation and polarization in mice.","volume":"9","author":"Li","year":"2018","journal-title":"Front Pharmacol"},{"key":"R33-20260710","doi-asserted-by":"crossref","first-page":"4727","DOI":"10.1002\/ptr.7104","article-title":"Quercetin as a protective agent for liver diseases: a comprehensive descriptive review of the molecular mechanism.","volume":"35","author":"Zhao","year":"2021","journal-title":"Phytother Res"},{"key":"R34-20260710","doi-asserted-by":"crossref","first-page":"1554","DOI":"10.1007\/s10620-014-3487-6","article-title":"Curcumin targets multiple pathways to halt hepatic stellate cell activation: updated mechanisms in vitro and in vivo.","volume":"60","author":"Tang","year":"2015","journal-title":"Dig Dis Sci"},{"key":"R35-20260710","doi-asserted-by":"crossref","first-page":"19320","DOI":"10.1002\/jcp.28626","article-title":"Demethoxycurcumin: a naturally occurring curcumin analogue for treating non-cancerous diseases.","volume":"234","author":"Hatamipour","year":"2019","journal-title":"J Cell Physiol"},{"key":"R36-20260710","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.biochi.2014.10.013","article-title":"Hypoxia-inducible factor-1alpha in hepatic fibrosis: a promising therapeutic target.","volume":"108","author":"Zhan","year":"2015","journal-title":"Biochimie"},{"key":"R37-20260710","doi-asserted-by":"crossref","first-page":"G582","DOI":"10.1152\/ajpgi.90368.2008","article-title":"Reduced liver fibrosis in hypoxia-inducible factor-1alpha-deficient mice.","volume":"296","author":"Moon","year":"2009","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"R38-20260710","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1007\/s00204-015-1472-2","article-title":"Compromised MAPK signaling in human diseases: an update.","volume":"89","author":"Kim","year":"2015","journal-title":"Arch Toxicol"},{"key":"R39-20260710","doi-asserted-by":"crossref","first-page":"2700","DOI":"10.3390\/ijms20112700","article-title":"ERK pathway in activated, myofibroblast-like, hepatic stellate cells: a critical signaling crossroad sustaining liver fibrosis.","volume":"20","author":"Foglia","year":"2019","journal-title":"Int J Mol Sci"},{"key":"R40-20260710","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1016\/j.jhep.2010.09.022","article-title":"Intracellular reactive oxygen species are required for directional migration of resident and bone marrow-derived hepatic pro-fibrogenic cells.","volume":"54","author":"Novo","year":"2011","journal-title":"J Hepatol"},{"key":"R41-20260710","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.mam.2018.09.002","article-title":"Liver fibrosis: pathophysiology, pathogenetic targets and clinical issues.","volume":"65","author":"Parola","year":"2019","journal-title":"Mol Asp Med"},{"key":"R42-20260710","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1002\/hep.1840170320","article-title":"Pentoxifylline prevents fibrosis in an animal model and inhibits platelet-derived growth factor-driven proliferation of fibroblasts.","volume":"17","author":"Peterson","year":"1993","journal-title":"Hepatol"},{"key":"R43-20260710","doi-asserted-by":"crossref","first-page":"40591","DOI":"10.1074\/jbc.M100975200","article-title":"N-acetylcysteine induces cell cycle arrest in hepatic stellate cells through its reducing activity.","volume":"276","author":"Kim","year":"2001","journal-title":"J Biol Chem"},{"key":"R44-20260710","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1159\/000453194","article-title":"Didymin alleviates hepatic fibrosis through inhibiting ERK and PI3K\/Akt pathways via regulation of Raf kinase inhibitor protein.","volume":"40","author":"Lin","year":"2016","journal-title":"Cell Physiol Biochem"},{"key":"R45-20260710","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1002\/hep.23189","article-title":"Inhibition of extracellular signal-regulated kinase 1 by adenovirus mediated small interfering RNA attenuates hepatic fibrosis in rats.","volume":"50","author":"Zhong","year":"2009","journal-title":"Hepatol"},{"key":"R46-20260710","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/S0092-8674(02)00966-2","article-title":"Ligand-induced, receptor-mediated dimerization and activation of EGF receptor.","volume":"20","author":"Schlessinger","year":"2002","journal-title":"Cell"},{"key":"R47-20260710","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/s00535-013-0907-x","article-title":"The EGFR signalling system in the liver: from hepatoprotection to hepatocarcinogenesis.","volume":"49","author":"Berasain","year":"2014","journal-title":"J Gastroenterol"},{"key":"R48-20260710","doi-asserted-by":"crossref","first-page":"30","DOI":"10.3390\/ijms17010030","article-title":"EGFR signaling in liver diseases.","volume":"17","author":"Komposch","year":"2015","journal-title":"Int J Mol Sci"},{"key":"R49-20260710","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1002\/hep.22437","article-title":"The epidermal growth factor receptor ligand amphiregulin participates in the development of mouse liver fibrosis.","volume":"48","author":"Perugorria","year":"2008","journal-title":"Hepatol"},{"key":"R50-20260710","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1111\/j.1872-034X.2012.01074.x","article-title":"Conditional knockout of heparin-binding epidermal growth factor-like growth factor in the liver accelerates carbon tetrachloride-induced liver injury in mice.","volume":"43","author":"Takemura","year":"2013","journal-title":"Hepatol Res"},{"key":"R51-20260710","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1002\/hep.26898","article-title":"Epidermal growth factor receptor inhibition attenuates liver fibrosis and development of hepatocellular carcinoma.","volume":"59","author":"Fuchs","year":"2014","journal-title":"Hepatol"},{"key":"R52-20260710","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1007\/s13238-016-0285-2","article-title":"Novel matrine derivative MD-1 attenuates hepatic fibrosis by inhibiting EGFR activation of hepatic stellate cells.","volume":"7","author":"Feng","year":"2016","journal-title":"Protein Cell"},{"key":"R53-20260710","doi-asserted-by":"crossref","first-page":"2019","DOI":"10.1002\/ijc.28299","article-title":"The molecular rationale of Src inhibition in colorectal carcinomas.","volume":"134","author":"Gargalionis","year":"2014","journal-title":"Int J Cancer"},{"key":"R54-20260710","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1007\/s10555-013-9481-1","article-title":"Src signaling pathways in prostate cancer.","volume":"33","author":"Varkaris","year":"2014","journal-title":"Cancer Metastasis Rev"},{"key":"R55-20260710","doi-asserted-by":"crossref","first-page":"359","DOI":"10.3389\/fphys.2015.00359","article-title":"Interplay of matrix stiffness and c-SRC in hepatic fibrosis.","volume":"6","author":"G\u00f6rtzen","year":"2015","journal-title":"Front Physiol"},{"key":"R56-20260710","first-page":"8","article-title":"TWEAK promotes hepatic stellate cell migration through activating EGFR\/Src and PI3K\/AKT pathways.","volume":"1","author":"Zhang","year":"2019","journal-title":"Cell Biol Int"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000034353","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,11]],"date-time":"2026-07-11T00:01:17Z","timestamp":1783728077000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000034353"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,21]]},"references-count":56,"journal-issue":{"issue":"29","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000034353","relation":{},"ISSN":["0025-7974"],"issn-type":[{"value":"0025-7974","type":"print"}],"subject":[],"published":{"date-parts":[[2023,7,21]]}}}